Source: International Congress 2014 – Genes and environment in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Accordini, L. Calciano, C. Bombieri, G. Malerba, F. Belpinati, M. Ferrari, A. R. Lo Presti, M. Olivieri, P. F. Pignatti, R. de Marco (Verona, Italy). The association among inflammation-related genes, fractional exhaled nitric oxide (FeNO), and symptom severity in adult asthma: A structural equation model (SEM). Eur Respir J 2014; 44: Suppl. 58, 2930

Member's Comments

No comment yet.

Related content which might interest you: Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 β2-Adrenoceptor polymorphisms and asthma phenotypes: interactions with passive smoking Source: Eur Respir J 2007; 30: 48-55 Year: 2007 Adult asthma, fraction of exhaled nitric oxide (FENO), and lung function Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009 Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients Source: Annual Congress 2013 –Treatment of asthma Year: 2013 iNOS expression is increased in peripheral airways of asthmatic patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 The relationship between the concentration of soluble icam-3 molecules and indicators of nitrosative stress in patients with an exacerbation of COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA) Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013 Repeatability of FeNO measurements with an airway inflammation monitor using the 6 second (6s) and the 10 second (10s) exhalation modes in children 6 to 10 years of age with asthma Source: International Congress 2014 – Airway biomarkers Year: 2014 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Meta analysis of asthma exacerbation rates in adult and pediatric asthmatics managed using fractional exhaled nitric oxide versus standard clinical parameters alone Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016